{
"info": {
"nct_id": "NCT00968682",
"official_title": "Detection of Cardiac Dysfunction in Patients Treated With Trastuzumab for HER-2 Positive Breast Cancer. The CADY Study",
"inclusion_criteria": "Healthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Presence of a medical or psychiatric condition, which, in the opinion of the investigator, would potentially pose a risk to the patient by participating in this trial.\n2. Evidence of metastatic disease.\n3. Patients with uncontrolled hypertension (sustained systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg), significant valvular disease (aortic or mitral regurgitation of 3 or 4+/ 4+ severity or stenosis of either valve), history of uncontrolled cardiac arrhythmias, prior symptomatic or asymptomatic myocardial infarction or angina pectoris requiring anti-anginal medication.\n4. Prior anthracycline or Trastuzumab therapy.\n5. Inability to give informed consent for any reason.",
"miscellaneous_criteria": "Inclusion Criteria\n\n1. HER-2 positive breast cancer by immunohistochemistry and/or fluorescence in-situ hybridisation.\n2. Planned neoadjuvant and/or adjuvant treatment with chemotherapy and Trastuzumab either sequentially or in combination or single agent Trastuzumab.\n3. 18 years of age or older.\n4. Disease Stage I-III, whose treatment plan includes Trastuzumab either sequentially, in combination or as a single agent will be eligible for inclusion in the study.\n5. As this is a non-interventional study, patients enrolled in therapeutic clinical trials will also be eligible for inclusion.\n6. Treatment with curative intent.\n7. ECOG Performance status 0, 1 or 2.\n8. Adequate cardiac function, with MUGA or Echocardiograph > 50%.\n9. Written informed consent."
},
"inclusion_lines": [
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "female"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "female"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "1. Presence of a medical or psychiatric condition, which, in the opinion of the investigator, would potentially pose a risk to the patient by participating in this trial.",
"criterions": [
{
"exact_snippets": "Presence of a medical or psychiatric condition",
"criterion": "medical or psychiatric condition",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Presence of a medical or psychiatric condition",
"criterion": "medical or psychiatric condition",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "in the opinion of the investigator, would potentially pose a risk to the patient by participating in this trial",
"criterion": "risk to the patient by participating in this trial",
"requirement": {
"requirement_type": "opinion of the investigator",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "2. Evidence of metastatic disease.",
"criterions": [
{
"exact_snippets": "Evidence of metastatic disease",
"criterion": "metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Evidence of metastatic disease",
"criterion": "metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "3. Patients with uncontrolled hypertension (sustained systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg), significant valvular disease (aortic or mitral regurgitation of 3 or 4+/ 4+ severity or stenosis of either valve), history of uncontrolled cardiac arrhythmias, prior symptomatic or asymptomatic myocardial infarction or angina pectoris requiring anti-anginal medication.",
"criterions": [
{
"exact_snippets": "uncontrolled hypertension (sustained systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg)",
"criterion": "hypertension",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
},
{
"exact_snippets": "uncontrolled hypertension (sustained systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg)",
"criterion": "hypertension",
"requirement": {
"requirement_type": "systolic blood pressure",
"expected_value": {
"operator": ">",
"value": 180,
"unit": "mmHg"
}
}
},
{
"exact_snippets": "uncontrolled hypertension (sustained systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg)",
"criterion": "hypertension",
"requirement": {
"requirement_type": "diastolic blood pressure",
"expected_value": {
"operator": ">",
"value": 100,
"unit": "mmHg"
}
}
},
{
"exact_snippets": "significant valvular disease (aortic or mitral regurgitation of 3 or 4+/ 4+ severity or stenosis of either valve)",
"criterion": "valvular disease",
"requirement": {
"requirement_type": "severity",
"expected_value": "significant"
}
},
{
"exact_snippets": "significant valvular disease (aortic or mitral regurgitation of 3 or 4+/ 4+ severity or stenosis of either valve)",
"criterion": "valvular disease",
"requirement": {
"requirement_type": "regurgitation",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "severity scale"
}
}
},
{
"exact_snippets": "significant valvular disease (aortic or mitral regurgitation of 3 or 4+/ 4+ severity or stenosis of either valve)",
"criterion": "valvular disease",
"requirement": {
"requirement_type": "stenosis",
"expected_value": "present"
}
},
{
"exact_snippets": "history of uncontrolled cardiac arrhythmias",
"criterion": "cardiac arrhythmias",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
},
{
"exact_snippets": "history of uncontrolled cardiac arrhythmias",
"criterion": "cardiac arrhythmias",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "prior symptomatic or asymptomatic myocardial infarction",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "symptomatic",
"expected_value": true
}
},
{
"exact_snippets": "prior symptomatic or asymptomatic myocardial infarction",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "asymptomatic",
"expected_value": true
}
},
{
"exact_snippets": "prior symptomatic or asymptomatic myocardial infarction",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "angina pectoris requiring anti-anginal medication",
"criterion": "angina pectoris",
"requirement": {
"requirement_type": "medication requirement",
"expected_value": "anti-anginal medication"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "uncontrolled hypertension (sustained systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg)",
"criterion": "hypertension",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
},
{
"or_criteria": [
{
"exact_snippets": "uncontrolled hypertension (sustained systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg)",
"criterion": "hypertension",
"requirement": {
"requirement_type": "systolic blood pressure",
"expected_value": {
"operator": ">",
"value": 180,
"unit": "mmHg"
}
}
},
{
"exact_snippets": "uncontrolled hypertension (sustained systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg)",
"criterion": "hypertension",
"requirement": {
"requirement_type": "diastolic blood pressure",
"expected_value": {
"operator": ">",
"value": 100,
"unit": "mmHg"
}
}
}
]
}
]
},
{
"and_criteria": [
{
"exact_snippets": "significant valvular disease (aortic or mitral regurgitation of 3 or 4+/ 4+ severity or stenosis of either valve)",
"criterion": "valvular disease",
"requirement": {
"requirement_type": "severity",
"expected_value": "significant"
}
},
{
"or_criteria": [
{
"exact_snippets": "significant valvular disease (aortic or mitral regurgitation of 3 or 4+/ 4+ severity or stenosis of either valve)",
"criterion": "valvular disease",
"requirement": {
"requirement_type": "regurgitation",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "severity scale"
}
}
},
{
"exact_snippets": "significant valvular disease (aortic or mitral regurgitation of 3 or 4+/ 4+ severity or stenosis of either valve)",
"criterion": "valvular disease",
"requirement": {
"requirement_type": "stenosis",
"expected_value": "present"
}
}
]
}
]
}
]
},
{
"and_criteria": [
{
"exact_snippets": "history of uncontrolled cardiac arrhythmias",
"criterion": "cardiac arrhythmias",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
},
{
"exact_snippets": "history of uncontrolled cardiac arrhythmias",
"criterion": "cardiac arrhythmias",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": "prior symptomatic or asymptomatic myocardial infarction",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "symptomatic",
"expected_value": true
}
},
{
"exact_snippets": "prior symptomatic or asymptomatic myocardial infarction",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "asymptomatic",
"expected_value": true
}
}
]
},
{
"exact_snippets": "prior symptomatic or asymptomatic myocardial infarction",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
{
"exact_snippets": "angina pectoris requiring anti-anginal medication",
"criterion": "angina pectoris",
"requirement": {
"requirement_type": "medication requirement",
"expected_value": "anti-anginal medication"
}
}
]
}
},
{
"identified_line": {
"line": "4. Prior anthracycline or Trastuzumab therapy.",
"criterions": [
{
"exact_snippets": "Prior anthracycline ... therapy",
"criterion": "anthracycline therapy",
"requirement": {
"requirement_type": "prior treatment",
"expected_value": true
}
},
{
"exact_snippets": "Prior ... Trastuzumab therapy",
"criterion": "Trastuzumab therapy",
"requirement": {
"requirement_type": "prior treatment",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Prior anthracycline ... therapy",
"criterion": "anthracycline therapy",
"requirement": {
"requirement_type": "prior treatment",
"expected_value": true
}
},
{
"exact_snippets": "Prior ... Trastuzumab therapy",
"criterion": "Trastuzumab therapy",
"requirement": {
"requirement_type": "prior treatment",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "5. Inability to give informed consent for any reason.",
"criterions": [
{
"exact_snippets": "Inability to give informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Inability to give informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
}
}
],
"miscellaneous_lines": [
{
"identified_line": {
"line": "1. HER-2 positive breast cancer by immunohistochemistry and/or fluorescence in-situ hybridisation.",
"criterions": [
{
"exact_snippets": "HER-2 positive breast cancer",
"criterion": "HER-2 status",
"requirement": {
"requirement_type": "status",
"expected_value": "positive"
}
},
{
"exact_snippets": "immunohistochemistry",
"criterion": "immunohistochemistry",
"requirement": {
"requirement_type": "method",
"expected_value": "used"
}
},
{
"exact_snippets": "fluorescence in-situ hybridisation",
"criterion": "fluorescence in-situ hybridisation",
"requirement": {
"requirement_type": "method",
"expected_value": "used"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "HER-2 positive breast cancer",
"criterion": "HER-2 status",
"requirement": {
"requirement_type": "status",
"expected_value": "positive"
}
},
{
"exact_snippets": "immunohistochemistry",
"criterion": "immunohistochemistry",
"requirement": {
"requirement_type": "method",
"expected_value": "used"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "HER-2 positive breast cancer",
"criterion": "HER-2 status",
"requirement": {
"requirement_type": "status",
"expected_value": "positive"
}
},
{
"exact_snippets": "fluorescence in-situ hybridisation",
"criterion": "fluorescence in-situ hybridisation",
"requirement": {
"requirement_type": "method",
"expected_value": "used"
}
}
]
}
]
}
},
{
"identified_line": {
"line": "2. Planned neoadjuvant and/or adjuvant treatment with chemotherapy and Trastuzumab either sequentially or in combination or single agent Trastuzumab.",
"criterions": [
{
"exact_snippets": "Planned neoadjuvant and/or adjuvant treatment with chemotherapy and Trastuzumab either sequentially or in combination",
"criterion": "planned neoadjuvant and/or adjuvant treatment",
"requirement": {
"requirement_type": "treatment type",
"expected_value": [
"chemotherapy",
"Trastuzumab"
]
}
},
{
"exact_snippets": "Planned neoadjuvant and/or adjuvant treatment with chemotherapy and Trastuzumab either sequentially or in combination",
"criterion": "planned neoadjuvant and/or adjuvant treatment",
"requirement": {
"requirement_type": "treatment sequence",
"expected_value": [
"sequentially",
"in combination"
]
}
},
{
"exact_snippets": "single agent Trastuzumab",
"criterion": "planned treatment",
"requirement": {
"requirement_type": "treatment type",
"expected_value": "single agent Trastuzumab"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Planned neoadjuvant and/or adjuvant treatment with chemotherapy and Trastuzumab either sequentially or in combination",
"criterion": "planned neoadjuvant and/or adjuvant treatment",
"requirement": {
"requirement_type": "treatment type",
"expected_value": [
"chemotherapy",
"Trastuzumab"
]
}
},
{
"exact_snippets": "Planned neoadjuvant and/or adjuvant treatment with chemotherapy and Trastuzumab either sequentially or in combination",
"criterion": "planned neoadjuvant and/or adjuvant treatment",
"requirement": {
"requirement_type": "treatment sequence",
"expected_value": [
"sequentially",
"in combination"
]
}
}
]
},
{
"exact_snippets": "single agent Trastuzumab",
"criterion": "planned treatment",
"requirement": {
"requirement_type": "treatment type",
"expected_value": "single agent Trastuzumab"
}
}
]
},
{
"exact_snippets": "single agent Trastuzumab",
"criterion": "planned treatment",
"requirement": {
"requirement_type": "treatment type",
"expected_value": "single agent Trastuzumab"
}
}
]
}
},
{
"identified_line": {
"line": "3. 18 years of age or older.",
"criterions": [
{
"exact_snippets": "18 years of age or older",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "18 years of age or older",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "4. Disease Stage I-III, whose treatment plan includes Trastuzumab either sequentially, in combination or as a single agent will be eligible for inclusion in the study.",
"criterions": [
{
"exact_snippets": "Disease Stage I-III",
"criterion": "disease stage",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1,
"unit": "N/A"
},
{
"operator": "<=",
"value": 3,
"unit": "N/A"
}
]
}
}
},
{
"exact_snippets": "treatment plan includes Trastuzumab",
"criterion": "treatment plan",
"requirement": {
"requirement_type": "inclusion",
"expected_value": "Trastuzumab"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Disease Stage I-III",
"criterion": "disease stage",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1,
"unit": "N/A"
},
{
"operator": "<=",
"value": 3,
"unit": "N/A"
}
]
}
}
},
{
"exact_snippets": "treatment plan includes Trastuzumab",
"criterion": "treatment plan",
"requirement": {
"requirement_type": "inclusion",
"expected_value": "Trastuzumab"
}
}
]
}
},
{
"identified_line": {
"line": "5. As this is a non-interventional study, patients enrolled in therapeutic clinical trials will also be eligible for inclusion.",
"criterions": [
{
"exact_snippets": "patients enrolled in therapeutic clinical trials",
"criterion": "enrollment in therapeutic clinical trials",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "patients enrolled in therapeutic clinical trials",
"criterion": "enrollment in therapeutic clinical trials",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "6. Treatment with curative intent.",
"criterions": [
{
"exact_snippets": "Treatment with curative intent.",
"criterion": "treatment intent",
"requirement": {
"requirement_type": "intent",
"expected_value": "curative"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Treatment with curative intent.",
"criterion": "treatment intent",
"requirement": {
"requirement_type": "intent",
"expected_value": "curative"
}
}
]
}
},
{
"identified_line": {
"line": "7. ECOG Performance status 0, 1 or 2.",
"criterions": [
{
"exact_snippets": "ECOG Performance status 0, 1 or 2.",
"criterion": "ECOG Performance status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"0",
"1",
"2"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ECOG Performance status 0, 1 or 2.",
"criterion": "ECOG Performance status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"0",
"1",
"2"
]
}
}
]
}
},
{
"identified_line": {
"line": "8. Adequate cardiac function, with MUGA or Echocardiograph > 50%.",
"criterions": [
{
"exact_snippets": "Adequate cardiac function",
"criterion": "cardiac function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "MUGA or Echocardiograph > 50%",
"criterion": "MUGA or Echocardiograph",
"requirement": {
"requirement_type": "percentage",
"expected_value": {
"operator": ">",
"value": 50,
"unit": "%"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Adequate cardiac function",
"criterion": "cardiac function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "MUGA or Echocardiograph > 50%",
"criterion": "MUGA or Echocardiograph",
"requirement": {
"requirement_type": "percentage",
"expected_value": {
"operator": ">",
"value": 50,
"unit": "%"
}
}
}
]
}
},
{
"identified_line": {
"line": "9. Written informed consent.",
"criterions": [
{
"exact_snippets": "Written informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "form",
"expected_value": "written"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Written informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "form",
"expected_value": "written"
}
}
]
}
},
{
"identified_line": {
"line": "Inclusion Criteria",
"criterions": []
},
"logical_structure": {
"and_criteria": []
}
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}